An actor who moved from South Africa to London to perform in the West End has revealed how cancer nearly wrecked his dream.

At the 2025 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium, Meara explored the ...

Actor loses half a lung after mistaking rare cancer for flu - He was diagnosed the same day he secured his first major West ...

The German company developed 177Lu-edotreotide to treat SSTR-positive gastroenteropancreatic neuroendocrine tumors and expects an agency decision in August.

Prescription Drug User Fee Act (PDUFA) goal date set for August 28, 2026Garching / Munich, Germany, November 13, 2025 – ITM Isotope Technologies ...

The firm has begun dosing extensive-stage small cell and Merkel cell cancer patients with 225Ac-SSO110 in a Phase I/II trial.

Ac-SSO110 has received U.S. FDA Orphan Drug DesignationInitial safety data from SANTANA-225 in ES-SCLC and MCC expected in 2026Potential to ...

Gov. Kelly Armstrong has designated Nov. 10, 2025, as NET Cancer Awareness Day in North Dakota, drawing attention to a rare ...

The IAEA has released a new e-learning course to help medical imaging specialists, oncologists and policymakers use a diagnostic tool that combines positron emission tomography and computed tomography ...

PanCAN Chief Scientific and Medical Officer Anna Berkenblit discusses how PanCAN supports all patients diagnosed with ...

In an interview with Targeted Oncology at the 2025 North American Neuroendocrine Tumor Society (NANETS) Symposium, Michael ...

Researchers recommend that future studies examine potential associations between survival and genomic mutations, clinical treatment history, and area deprivation index.